Arterial and venous thromboembolic disease in a patient with COVID 19: A case report

Renée Brüggemann,Hester Gietema,Borefore Jallah,Hugo ten Cate,Coen Stehouwer,Bart Spaetgens

Thrombosis Research（2020）

引用 33|浏览6

暂无评分

摘要

•Hypercoagulability is a major contributor to COVID-19 related pulmonary complications•Commonly used approaches may be insufficient to ameliorate the risk of thromboembolic events in patients with COVID-19•Even when on thromboprophylaxis, it is crucial to remain vigilant for the occurrence of VTE in patients with COVID-19.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要